6 latest FDA approvals

Here are the six latest drugs or medical devices approved by the FDA since May 11.

1. Gilenya, a disease-modifying therapy, may now be used to treat children 10 and up with multiple sclerosis.

2. Lucemyra is the first nonopioid treatment for adults managing opioid withdrawal symptoms.

3. Retacrit is a biosimilar version of the anemia therapy Epogen/Procrit.

4. BacterioScan 216DX transmits a laser through urine samples to detect bacteria associated with urinary tract infections.

5. Lokelma is intended to treat patients with hyperkalemia, a condition involving elevated potassium levels in the blood.

6. Doptelet is used to treat thrombocytopenia — a condition involving a low blood platelet count — in chronic liver disease patients set to undergo a medical or dental procedure.

More articles on supply chain:

How Mass General is dealing with the worst opioid shortage in years: 7 things to know
90% of ER physicians had shortages of critical medicine in the last month: 5 notes
Supply chain salaries jumped 4% in 2017: 5 things to know

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars